Pharmacological study on bone metabolism by nervous activity
神经活动对骨代谢的药理学研究
基本信息
- 批准号:17591956
- 负责人:
- 金额:$ 2.36万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The vertebrate skeleton is richly innervated with adrenergic and peptidergic nerve terminals, and these play important roles in bone remodelling. Recently showed that increased sympathetic nervous activity causes bone loss via an increase in bone resorption and a decrease in bone formation. Increased bone resorption is based on the stimulation of both osteoclast formation and osteoclast activity. And we also demonstrated that human osteoblastic as well as osteoclastic cells are equipped with adrenergic receptors (Ars) and neuropeptide receptors and that they constitutively express diffusible axon guidance molecules known to function as a chemoattractant and/or chemorepellent for growing nerve fibers. These findings suggest that the extension of axons of sympathetic and peripheral sensory neurons to osteoblastic and osteoclastic cells is required for the dynamic neural regulation of local bone metabolism. However, while several studies have shown a functional nerve-bone cell interplay, … More whether both osteoblastic and osteoclastic cells activation occurs as a direct response to neuronal activation or requires an intermediary cell is unclear. Therefore, we examined direct nerve-osteoblastic cell communication by using an in vitro co-culture model comprising mouse osteoblastic cells, MC3T3-El, and neurite-spouting mouse superior cervical ganglia. Following loading with the calcium fluorophore Fluo-3, neurite-osteoblastic cell units were examined by confocal laser scanning microscopy. The addition of scorpion venom (SV) elicited neurite activation (i.e., Ca^<2+> mobilization) and, after a lag period, osteoblastic Ca^<2+> mobilization. The SV had no direct effect on the MC3T3-El cells in the absence of neurites. The addition of an α1-AR antagonist, prazosin concentration-dependently prevented the osteoblastic activation that resulted as a consequence of the neural activation by SV. Thus, our recent findings demonstrate that MC3T3-E1 activation, as judge by Ca^<2+> mobilization, can be a direct consequence of contact with a specific activated nerve fiber. This evidence obtained in vitro demonstrates that nerve-osteoblastic cell cross-talk can occur in the absence of an intermediary transducing cell and that noradrenaline is an important mediator of this communication. Several recent in vivo and in vitro studies have demonstrated a sympathomimetic action on bone formation and resorption via osteoblastic and osteoclastic cells, respectively, expressing α-and β-Ars. Less
脊椎动物骨骼富含肾上腺素能和肽能神经末梢,这些神经末梢在骨重塑中发挥着重要作用。最近表明,交感神经活动的增加通过骨吸收的增加和骨形成的减少导致骨质流失。骨吸收的增加是基于破骨细胞形成和破骨细胞活性的刺激。我们还证明,人类成骨细胞和破骨细胞都配备有肾上腺素能受体(Ars)和神经肽受体,并且它们组成型表达可扩散的轴突引导分子,已知这些分子可作为神经纤维生长的化学引诱剂和/或化学排斥剂。这些发现表明,局部骨代谢的动态神经调节需要交感神经和外周感觉神经元的轴突延伸至成骨细胞和破骨细胞。然而,虽然一些研究表明功能性神经骨细胞之间存在相互作用,但成骨细胞和破骨细胞的激活是否是对神经元激活的直接反应,还是需要中间细胞,尚不清楚。因此,我们通过使用包含小鼠成骨细胞、MC3T3-E1和神经突喷出小鼠颈上神经节的体外共培养模型来检查直接神经-成骨细胞通讯。加载钙荧光团 Fluo-3 后,通过共焦激光扫描显微镜检查神经突成骨细胞单元。添加蝎毒(SV)引起神经突激活(即Ca 2+ 动员),并且在滞后期后引起成骨细胞Ca 2+ 动员。在不存在神经突的情况下,SV对MC3T3-E1细胞没有直接影响。添加 α1-AR 拮抗剂哌唑嗪浓度依赖性地阻止了由于 SV 神经激活而导致的成骨细胞激活。因此,我们最近的研究结果表明,根据Ca 2+ 动员判断,MC3T3-E1 激活可能是与特定激活神经纤维接触的直接结果。体外获得的证据表明,神经-成骨细胞间的交流可以在没有中间转导细胞的情况下发生,并且去甲肾上腺素是这种交流的重要介质。最近的几项体内和体外研究表明,分别通过表达 α-Ars 和 β-Ars 的成骨细胞和破骨细胞对骨形成和骨吸收具有拟交感神经作用。较少的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ヒト骨芽細胞のERKリン酸化に対するβ2アドレナリン調節機構
β2-肾上腺素能对人成骨细胞ERK磷酸化的调节机制
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:蛭川 幸史;戸苅 彰史
- 通讯作者:戸苅 彰史
Pharmacological topics of bone metabolism:The sympathetic nervous system in modulating bone resorption
骨代谢的药理学主题:交感神经系统调节骨吸收
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Togari;A.;Arai;M.
- 通讯作者:M.
Demonstration of direct neurite-osteoblastic cell communication in vitro co-culture system.
体外共培养系统中直接神经突-成骨细胞通讯的演示。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Obata;K.;Furuno;T.;Nakanishi;M.;Togari;A.
- 通讯作者:A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOGARI Akifumi其他文献
TOGARI Akifumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOGARI Akifumi', 18)}}的其他基金
Pharmacological study on increased bone formation by alpha1-adrenoceptor signaling in bone metabolism.
骨代谢中α1-肾上腺素受体信号增加骨形成的药理学研究。
- 批准号:
26462827 - 财政年份:2014
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacological study on circadian gene expression induced by sympathetic nervous activity in osteoblastic cells.
交感神经活动诱导成骨细胞昼夜节律基因表达的药理学研究。
- 批准号:
20592193 - 财政年份:2008
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacological Study on Neuronal Regulation of Osteoclast Formation
破骨细胞形成的神经调节药理学研究
- 批准号:
14571782 - 财政年份:2002
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacological Study on Neural Regulation of Bone Metabolism
骨代谢神经调控的药理学研究
- 批准号:
11671861 - 财政年份:1999
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacological study on NO and biopterin synthesis in osteoblastic cells
成骨细胞合成NO和生物蝶呤的药理学研究
- 批准号:
09671912 - 财政年份:1997
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
ICF Biologically derived wraps for nerve and tendon regeneration
ICF 生物衍生包裹物,用于神经和肌腱再生
- 批准号:
MR/Z503733/1 - 财政年份:2024
- 资助金额:
$ 2.36万 - 项目类别:
Research Grant
Targeting axonal transport regulation by neurotrophic factors to treat peripheral nerve degeneration
通过神经营养因子调节轴突运输来治疗周围神经变性
- 批准号:
MR/Y010949/1 - 财政年份:2024
- 资助金额:
$ 2.36万 - 项目类别:
Fellowship
Canadian Peripheral Nerve Research Collaborative - National Research Symposium
加拿大周围神经研究合作组织 - 国家研究研讨会
- 批准号:
480818 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Miscellaneous Programs
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A human 3D bone-sensory nerve co-culture model to investigate bone-derived pain
用于研究骨源性疼痛的人体 3D 骨感觉神经共培养模型
- 批准号:
NC/Y000951/1 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Research Grant
Antiarrhythmic mechanisms of chronic vagal nerve stimulation in sympathetic neurons
交感神经元慢性迷走神经刺激的抗心律失常机制
- 批准号:
10635151 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Commercialization Readiness for Nerve Tape: a nerve repair coaptation aid
神经胶带的商业化准备:神经修复接合辅助工具
- 批准号:
10698977 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma
个性化青光眼环视乳头视网膜神经纤维层厚度标准
- 批准号:
10728042 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Investigating the Mechanism of Optic Nerve disorders associated with Down Syndrome
研究与唐氏综合症相关的视神经疾病的机制
- 批准号:
10658120 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别: